Chen Yun-Ju, Wang Ying-Nai, Chang Wen-Chang
Department of Pharmacology, National Cheng Kung University, Tainan 701, Taiwan; Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan.
Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030.
J Biol Chem. 2007 Sep 14;282(37):27215-27228. doi: 10.1074/jbc.M700264200. Epub 2007 Jul 9.
We previously reported that the epidermal growth factor (EGF) regulates the gene expression of keratin 16 by activating the extracellular signal-regulated kinase 1 and 2 (ERK1/2) signaling which in turn enhances the recruitment of p300 to the keratin 16 promoter. The recruited p300 functionally cooperates with Sp1 and c-Jun to regulate the gene expression of keratin 16. This study investigated in detail the molecular events incurred upon p300 whereby EGF caused an enhanced interaction between p300 and Sp1. EGF apparently induced time- and dose-dependent phosphorylation of p300, both in vitro and in vivo, through the activation of ERK2. The six potential ERK2 phosphorylation sites, including three threonine and three serine residues as revealed by sequential analysis, were first identified in vitro. Confirmation of these six sites in vivo indicated that these three serine residues (Ser-2279, Ser-2315, and Ser-2366) on the C terminus of p300 were the major signaling targets of EGF. Furthermore, the C-terminal serine phosphorylation of p300 stimulated its histone acetyltransferase activity and enhanced its interaction with Sp1. These serine phosphorylation sites on p300 controlled the p300 recruitment to the keratin 16 promoter. When all three serine residues on p300 were replaced by alanine, EGF could no longer induce the gene expression of keratin 16. Taken together, these results strongly suggested that the ERK2-mediated C-terminal serine phosphorylation of p300 was a key event in the regulation of EGF-induced keratin 16 expression. These results also constituted the first report identifying the unique p300 phosphorylation sites induced by ERK2 in vivo.
我们之前报道过,表皮生长因子(EGF)通过激活细胞外信号调节激酶1和2(ERK1/2)信号通路来调控角蛋白16的基因表达,进而增强p300与角蛋白16启动子的结合。募集到的p300与Sp1和c-Jun协同作用,调控角蛋白16的基因表达。本研究详细探究了p300所引发的分子事件,即EGF如何导致p300与Sp1之间的相互作用增强。EGF在体外和体内均通过激活ERK2,明显诱导了p300的时间和剂量依赖性磷酸化。通过序列分析首次在体外鉴定出六个潜在的ERK2磷酸化位点,包括三个苏氨酸和三个丝氨酸残基。在体内对这六个位点的确认表明,p300 C端的这三个丝氨酸残基(Ser-2279、Ser-2315和Ser-2366)是EGF的主要信号转导靶点。此外,p300的C端丝氨酸磷酸化刺激了其组蛋白乙酰转移酶活性,并增强了其与Sp1的相互作用。p300上的这些丝氨酸磷酸化位点控制了p300向角蛋白16启动子的募集。当p300上的所有三个丝氨酸残基都被丙氨酸取代时,EGF就不再能诱导角蛋白16的基因表达。综上所述,这些结果强烈表明,ERK2介导的p300 C端丝氨酸磷酸化是EGF诱导角蛋白16表达调控中的关键事件。这些结果也构成了首篇在体内鉴定出由ERK2诱导的p300独特磷酸化位点的报道。